NY Times

Advertismentspot_img

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”  » mehr lesen

Southwest Stole Christmas. It Still Has Superfans.

It’s been a disastrous week for the budget airline. But its influencers are prepared to defend their brand loyalty.  » mehr lesen

Tax Credits for Electric Vehicles Are About to Get Confusing

Foreign-made cars no longer qualify. Tesla and G.M. should become eligible again. But officials are still working on the fine print.  » mehr lesen

SpaceX’s Launch Control Room: 3 Rocket Missions in 31 Hours

A reporter got an inside look at SpaceX’s attempt to launch and land three rockets in less than two days in October, part of the company’s bid to make spaceflight appear almost...

More Mass Cancellations as Southwest Struggles to Untangle Travel Meltdown

The airline canceled more than half its flights on Thursday, nearly a week after a winter storm disrupted holiday travel across the United States.  » mehr lesen

The 2022 Good Tech Awards

Nuclear fusion, generative A.I., bee tracking and more. There’s a lot to like.  » mehr lesen

As Silicon Valley Retrenches, a Tech Talent Shift Accelerates

Most tech jobs are now in mainstream industries like health care, banking and retail, which are increasingly in need of workers with digital skills.  » mehr lesen

The Tech That Will Invade Our Lives in 2023

Say hello to new-and-improved A.I. assistants, and move over to brands like Twitter and Tesla.  » mehr lesen

NY Times

Advertismentspot_img